Function and sleep in Pulmonary TB

Not Applicable

Completed

• Conditions: Health Condition 1: J40-J47- Chronic lower respiratory diseasesHealth Condition 2: J99- Respiratory disorders in diseasesclassified elsewhere

• Registration Number: CTRI/2022/12/048321
• Lead Sponsor: Seth G S Medical College and KEMH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2023-09-01
• Last Update Posted: 18 September 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 47

Inclusion Criteria

Patients evaluated and assessed by chest physician and diagnosed with pulmonary tuberculosis.

Started and are on Anti Tuberculosis treatment (ATT) at least 3 months ago but not more than 3 years.

Sputum samples tested negative for Acid Fast Bacilli at least 1 month ago

Exclusion Criteria

Patients who have already completed anti-tuberculous treatment for more than 3 years ago.

Pregnant and lactating women.

Patients with miliary and extrapulmonary tuberculosis.

Patients who have been diagnosed with hepatotoxicity by the physicians

Patients with any known neurological, musculoskeletal and hearing impairments. Patients with any associated primary cardiovascular disease, preexisting asthma/chronic obstructive

pulmonary

Patients with hemoptysis, chest pain

Patients with MMRC grade 4 breathlessness

Patients prescribed with psychotropic drugs, anti- histamines

Patients enrolled into rehabilitation program

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br/ ><br>1 Minute Sit-to-Stand Test <br/ ><br> <br/ ><br>Timepoint: baseline <br/ ><br> <br/ ><br> <br/ ><br>

Secondary Outcome Measures

Name	Time	Method
nilTimepoint: nil